Internationale samarbejder

Risk of cancer in patients with psoriatic arthritis threated with biologics – a population-based study in the Nordic countries. Lene Dreyer, René Cordtz. Collaborators: Björn Guðbjörnsson, Merete Lund Hetland, Johan Askling, Dan Nordström, Kalle Aaltonen
Risk of multiple sclerosis and inflammatory polyneuropathies in arthritis patients treated with biologics – a population-based study from the Nordic countries. Lene Dreyer. Collaborators: Tine Iskov Kopp, Jesper Lindhardsen, Björn Guðbjörnsson, Johan Askling, Aikaterini Chatzidionysiou, Dan Nordström, Kalle Aaltonen, Bénédicte Delcoigne
The effect of JAK inhibitors on venous thromboembolism and viral infection risk in patients with Rheumatoid Arthritis. Lene Dreyer, René Cordtz. Collaborators: Andrea Burden, Maria Luisa Marques de Sá Faquetti, Vallejo Yagüe Enriqueta
The effect of JAK inhibitors – The JAKPOT Consortium. Lene Dreyer, René Cordtz. Collaborators: Kim Lauper, Denis Mongin, Sytske Anne Bergstra, Denis Choquette, Catalin Codreanu, Diederik De Cock , Ori Elkayam, Kimme Hyrich, Florenzo Iannone, Nevsun Inanc, Eirik K. Kristianslund, Tore K. Kvien, Burkhard Leeb, Galina Lukina, Dan Nordström, Karel Pavelka, Manuel Pombo-Suarez, Ziga Rotar, Maria Jose Santos, Anja Strangfeld, Delphine Courvoisier, Axel Finckh
Effect and adverse events in Juvenile Arthritis: A Cochrane review. Lene Dreyer. Collaborators: Giovanni Cagnotto, Matteo Bruschettini, Ingemar Petersson, Michele Compagno, Carsten Juhl, Fredrik Ahlström
EULAR portfolio for training in rheumatology: a EULAR School of Rheumatology initiative. Mette Holland-Fischer. Collaborators: Marloes van Onna, Sofia Ramiro, Catherine Haines, Jose da Silva, Jean Dudler, Chris Edwards, Alessia Alunno, Elena Nikiphorou, Louise Falzon, Francisca Sivera: Working group on Development of a EULAR portfolio of Rheumatology
Task Force for the development of EULAR recommendations for a core data set to support research and clinical care in SLE. Lene Dreyer. Collaborators: EULAR Task Force group